Literature DB >> 8464816

Disposition of azole antifungal agents. I. Nonlinearities in ketoconazole clearance and binding in rat liver.

D Matthew1, B Brennan, K Zomorodi, J B Houston.   

Abstract

The disposition of ketoconazole was characterized in the rat over a wide dose/concentration range. Bolus dose (0.03-10 mg/kg) studies indicate that plasma concentration-time profiles for ketoconazole are not superimposable when dose normalized because of nonlinearities occurring in both volume of distribution and clearance. The volume of distribution decreases from 3 to less than 1 L/kg, while the plasma clearance decreases 10-fold from 25 mL/min/kg as the dose is escalated. From these results, infusion rates were calculated to maintain the plasma concentrations achieved with particular bolus doses. The curvilinear relationship between steady-state plasma concentration (0.015-8.3 mg/L) and ketoconazole infusion rate (0.021-2.45 mg/hr/kg) was analyzed in terms of Michaelis-Menten kinetics. A Vmax of 3.2 mg/hr/kg and Km of 2.1 mg/L were obtained by nonlinear regression analysis. At the end of the ketoconazole infusion, liver, adrenals and kidneys were removed and assayed for ketoconazole. Tissue-to-plasma partition coefficients for the liver and adrenals showed a marked dependence upon steady-state plasma concentration. Both parameters (liver, 22; and adrenals, 53) showed a decrease of approximately 10-fold as the plasma concentrations were increased. In contrast, the kidney:plasma partition coefficient (1.8), blood:plasma concentration ratio (0.6), and plasma binding (96%) of ketoconazole did not show a concentration dependence over the range studied. It is concluded that the liver is an important determinant of ketoconazole's volume of distribution and that saturation of this process accounts largely for the reduction in volume of distribution with increasing dose.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464816     DOI: 10.1023/a:1018996524141

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins.

Authors:  A D Rodrigues; G G Gibson; C Ioannides; D V Parke
Journal:  Biochem Pharmacol       Date:  1987-12-15       Impact factor: 5.858

2.  Dose-dependent pharmacokinetics of cimetidine in the rat.

Authors:  A Adedoyin; L Aarons; J B Houston
Journal:  Xenobiotica       Date:  1987-05       Impact factor: 1.908

Review 3.  Factors affecting drug metabolism.

Authors:  J R Gillette
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

4.  A rapid and simple procedure for chronic cannulation of the rat jugular vein.

Authors:  P G Harms; S R Ojeda
Journal:  J Appl Physiol       Date:  1974-03       Impact factor: 3.531

Review 5.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

6.  The interaction of representative members from two classes of antimycotics--the azoles and the allylamines--with cytochromes P-450 in steroidogenic tissues and liver.

Authors:  I Schuster
Journal:  Xenobiotica       Date:  1985-06       Impact factor: 1.908

7.  Ketoconazole. Use in the treatment of ectopic adrenocorticotropic hormone production and Cushing's syndrome in small-cell lung cancer.

Authors:  F A Shepherd; B Hoffert; W K Evans; G Emery; J Trachtenberg
Journal:  Arch Intern Med       Date:  1985-05

8.  Inhibition of human hepatic and placental xenobiotic monooxygenases by imidazole antimycotics.

Authors:  M Pasanen; T Taskinen; M Iscan; E A Sotaniemi; M Kairaluoma; O Pelkonen
Journal:  Biochem Pharmacol       Date:  1988-10-15       Impact factor: 5.858

9.  Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.

Authors:  J J Sheets; J I Mason
Journal:  Drug Metab Dispos       Date:  1984 Sep-Oct       Impact factor: 3.922

10.  Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose.

Authors:  G M Pollack; K L Brouwer; K B Demby; J A Jones
Journal:  Drug Metab Dispos       Date:  1990 Mar-Apr       Impact factor: 3.922

View more
  6 in total

1.  Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes.

Authors:  Kiyomi Ito; J Brian Houston
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

Review 2.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

3.  Physiologically based pharmacokinetic modeling of SNU-0039, an anti-Alzheimer's agent, in rats.

Authors:  Kyeong-Ryoon Lee; Yoon-Jee Chae; Han-Joo Maeng; Jeewoo Lee; Dae-Duk Kim; Saeho Chong; Chang-Koo Shim; Suk-Jae Chung
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-08-25       Impact factor: 2.745

4.  Predicting the Drug-Drug Interaction Mediated by CYP3A4 Inhibition: Method Development and Performance Evaluation.

Authors:  Hong-Can Ren; Yang Sai; Tao Chen; Chun Zhang; Lily Tang; Cheng-Guang Yang
Journal:  AAPS J       Date:  2021-12-10       Impact factor: 4.009

5.  Disposition of azole antifungal agents. III. Binding of fluconazole and other azoles in rat liver.

Authors:  C M Ervine; J B Houston
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

6.  Disposition of azole antifungal agents. II. Hepatic binding and clearance of dichlorophenyl-bis-triazolylpropanol (DTP) in the rat.

Authors:  H L Bomont; M H Tarbit; M J Humphrey; J B Houston
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.